Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 37843857

Zoledronic Acid Add-on Therapy for Standard-Risk Ewing Sarcoma Patients in the Ewing 2008R1 Trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Clin Cancer Res
Publication date
2023 Dec 15
First author
Koch R

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Koch R
      type
      Author
    2. name
      Haveman L
      type
      Author
    3. name
      Ladenstein R
      type
      Author
    4. name
      Brichard B
      type
      Author
    5. name
      Jürgens H
      type
      Author
    6. name
      Cyprova S
      type
      Author
    7. name
      van den Berg H
      type
      Author
    8. name
      Hassenpflug W
      type
      Author
    9. name
      Raciborska A
      type
      Author
    10. name
      Ek T
      type
      Author
    11. name
      Baumhoer D
      type
      Author
    12. name
      Egerer G
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Koch R
      type
      Author
    2. name
      Haveman L
      type
      Author
    3. name
      Ladenstein R
      type
      Author
    4. name
      Brichard B
      type
      Author
    5. name
      Jürgens H
      type
      Author
    6. name
      Cyprova S
      type
      Author
    7. name
      van den Berg H
      type
      Author
    8. name
      Hassenpflug W
      type
      Author
    9. name
      Raciborska A
      type
      Author
    10. name
      Ek T
      type
      Author
    11. name
      Baumhoer D
      type
      Author
    12. name
      Egerer G
      type
      Author
    bibliography ids
    1. nci-bib-167c6aed87eabb4b2686fa3b
    book metadata
    content sha256
    28f9f045b5a2e347daeee089eea69909a825c6bc1e1744e8ac49c214989cb4dd
    document type
    citation
    dois
    1. 10.1158/1078-0432.CCR-23-1966
    electronic publication date
    display
    Source null
    precision
    missing
    year
    Source null
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:37843857
    immutable id
    pubmed:37843857@28f9f045b5a2e347daeee089eea69909a825c6bc1e1744e8ac49c214989cb4dd
    journal
    abbreviation
    Clin Cancer Res
    issn electronic
    1557-3265
    issn print
    1078-0432
    issue
    24
    name
    Clinical cancer research : an official journal of the American Association for Cancer Research
    nlm unique id
    9502500
    pages
    5057-5068
    volume
    29
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      37843857
      provenance
      batch id
      5329a5d0877ee70ecd11
      provider
      NCBI PubMed ESummary
      record sha256
      20bc2898c67c7d8555f8d7b69539c764ce338ef55fd030f57e789fbe5ef3d7cb
      response sha256
      bcc4d4935bae07b2d0bf7ef24187cf1ff9d849601f315c9dbe2002bd5de6f631
      retrieved at
      2026-09-09T23:48:15.763286+00:00
      publication date
      display
      2023 Dec 15
      precision
      day
      year
      2023
      publication types
      1. Randomized Controlled Trial
      2. Multicenter Study
      3. Clinical Trial, Phase III
      4. Journal Article
      5. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/37843857/
      title
      Zoledronic Acid Add-on Therapy for Standard-Risk Ewing Sarcoma Patients in the Ewing 2008R1 Trial.

      Preserved source evidence · Not medical advice